International journal of molecular sciences
Cure8 research brief
Why This Matters
This study identifies molecular targets and organoid-based effects of ganoderic acid A on inflammatory pathways relevant to IBD, pointing to a potential multi-target avenue for future drug-discovery research.
Who Should Pay Attention
Researchers studying IBD mechanisms or drug discovery, translational clinicians interested in novel preclinical therapies, and biomedical scientists working on MAPK, TNF signaling, or ferroptosis in intestinal disease.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
The paper combines network pharmacology (database target mapping and gene co-expression analysis), molecular docking, and experimental validation in cytokine/LPS-treated intestinal organoids to explore how GAA might affect pathways implicated in IBD. Docking predicted high-affinity binding to targets such as TNF-α, PPARγ, MAPK14, PIK3CA, and CASP3.
In organoids, GAA reduced elevated TNF-α and phosphorylated MAPK14 levels in the inflammatory model used. This is preclinical, mechanistic work using in silico methods and organoid experiments — not a clinical trial.
The authors note possible links to ferroptosis-related genes but did not report direct ferroptosis biomarker measurements in the organoid experiments. Next steps would be further mechanistic studies, reproducibility in additional models, and safety/pharmacology before any human research.
Keep In Mind
Structured content depth is an abstract-based summary of a journal article: the report is preclinical (network pharmacology, molecular docking, and organoid experiments) and does not provide clinical efficacy or safety data. The link to ferroptosis is suggested by gene overlap and requires direct biomarker validation.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationInternational journal of molecular sciences
AuthorsCai M, Sun M, Li K +3 more
Study typeIm, journal article
Indexed viaEurope PMC
Source typeResearch paper
PublishedJun 24, 2026, 12:00 AM
Content availableJournal abstract
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Multi-omics Mendelian randomization and experimental validation identify PRKAB1 as a regulator of phosphatidylcholine metabolism in IBD.
Phosphatidylcholines are implicated in IBD biology; identifying a gene that regulates PC metabolism could point to new mechanistic targets. If PRKAB1 modulates epithelial lipid metabolism relevant to inflammation, it may...
TNFAIP1 as a novel therapeutic target in ulcerative colitis and salidroside as its potential inhibitor.
The study identifies a previously unrecognized protein (TNFAIP1) that appears to promote inflammation in ulcerative colitis and proposes a compound (Salidroside) that directly binds and inhibits it in lab and mouse...
Glycocholic acid inhibits TRIB3-ID1 axis to acelerate colitis progression via suppressing intestinal stem cell renewal.
The paper proposes a specific molecular link between elevated glycocholic acid (a bile acid altered in IBD) and impaired intestinal stem cell renewal via the TRIB3–ID1 pathway, which could help explain poor mucosal...